Found "Medical Procedures": 289 results
Sort by
Relevance

The Economic Evaluation of Medical Devices: Challenges (2014)

Pritaporn Kingkaew BPharm, MSc*, Yot Teerawattananon MD, PhD* * Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand While many of the principles that guide the economic evaluation of medical devices are somewhat similar to those that guide the evaluation of other

A Determination of Topics for Health Technology Assessment in Thailand: Case Study for Decision Makers Participation (2007-2008) (in Thai language)

An aim of this study is to describe quantitatively and qualitatively progression and findings from the HTA topic selection process recently developed by HITAP. The process involves potential users of HTA information; namely (1) third party payers (public health insurers), (2) national health care program managers (Ministry of Public Health’s Depa

Review of Literature and Information to Support and Pilot testing the Process for Integrating Thai Innovation into Thailand’s Universal Health Coverage System: A Case Study of Advance Wound Dressing from the Thai Innovation List

The development of health and medical innovation is a key national strategy for Thailand under the 13th National Economic and Social Development Plan, which aims to position the country as a high-value medical and wellness hub while reducing dependence on imported medical technologies. The Thai Innovation List was established to promote the commerc

Priority setting for health innovation and Early Health Technology Assessment for supporting research and development of medical innovation in Thailand (Fiscal Year 2026)

The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr

Priority setting for health innovation and Early Health Technology Assessment for supporting research and development of medical innovation in Thailand (Fiscal year 2025)

The development of medical innovation is one of Thailand’s key strategic priorities as outlined in the 13th National Economic and Social Development Plan (2023–2027). Milestone 4 identifies Thailand’s ambition to become a high-value medical and wellness hub, with the goal of strengthening the country’s capacity to generate economic value fr

Reducing low-value care for the sustainable value-based healthcare system

Value-Based Healthcare aims to ensure that everyone receives appropriate, high-quality care that delivers the best possible health outcomes while making efficient use of healthcare resources. However, some medical procedures and services may offer little benefit compared with their potential risks,

Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program.(2009)

Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program. Tantivess S1 Teerawattananon Y1 Mills A1 1 Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand 2 London

Involvement of consumers in health technology assessment activities by INAHTA agencies (2013)

Involvement of consumers in health technology assessment activities by INAHTA agencies. David Haileya1, Sophie Werköa2, Rugayah Bakria3, Alun Camerona4, Britta Göhlena5, Susan Mylesa6, Jasmine Pwua7 and Jomkwan Yothasamuta8 For the INAHTA Working Group on Impact of HTA a1 University of Wollong

Health Financing during COVID-19 responses in Thailand

Thailand spent 440,023 million baht on healthcare in response to the COVID-19 pandemic in 2020–2022, of which 257,892 million baht went toward COVID-19 tests, treatments, and vaccination services. In addition to having higher hospital reserves than in the pre-pandemic period, private hospital

DNA Blueprint for Fetus Built Using Tests of Parents

For the first time, researchers have determined virtually the entire genome of a fetus using only a blood sample from the pregnant woman and a saliva specimen from the father.The accomplishment heralds an era in which parents might find it easier to know the complete DNA blueprint of a child months
10 / Page